Global Narcolepsy Market Insight, Epidemiology and Forecast to 2027 - ResearchAndMarkets.com

June 5, 2018

DUBLIN--(BUSINESS WIRE)--Jun 5, 2018--The “Narcolepsy- Market Insight, Epidemiology and Market Forecast - 2027” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Narcolepsy in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Narcolepsy from 2016 to 2027 segmented by seven major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.


Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies


10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition


Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers

Companies Mentioned

NLS Pharma - Jazz Pharma Avadel - Sanofi - Aventis Taisho Pharmaceuticals Balance Therapeutics Bioprojet Theranexus

Key Topics Covered

1. Key Insights

2. Narcolepsy Market Overview at a Glance

3. Disease Background and Overview: Narcolepsy

4. Epidemiology and Patient Population

5. 7MM Total Prevalent Patient Population of Narcolepsy

6. Current Treatment and Medical Practices

7. Unmet Needs

8. Marketed drugs

9. Other Narcoleptics

10. Emerging Drugs

11. Narcolepsy: 7 Major Market Analysis

12. Narcolepsy: 7 Major Market Outlook

13. Market Size of Narcolepsy in 7MM

14. Market Outlook by Country

15. Market Drivers

16. Market Barriers

17. Appendix

18. Report Methodology

19. Capabilities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/nf577q/global_narcolepsy?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180605006568/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/05/2018 02:46 PM/DISC: 06/05/2018 02:46 PM


Update hourly